Pretreatment with genistein significantly improved ulcer indexes and increased the level of NO, PGE2 and SOD activity and significantly decreased MDA, levels of TNF-α and MPO activity, and expression of MMP-9 was negatively regulated [126]. The gene discussed is MPO; the disease is ulcer disease.